Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
56.3 USD | +0.68% | +0.50% | +25.37% |
Apr. 12 | Zacks Investment Research Downgrades Catalent to Underperform From Neutral, Price Target is $48 | MT |
Apr. 08 | Sector Update: Health Care Stocks Decline Late Afternoon | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+25.37% | 10.12B | |
+26.16% | 661B | |
+26.86% | 566B | |
-6.58% | 352B | |
+20.38% | 332B | |
+2.50% | 283B | |
+13.62% | 231B | |
+5.08% | 200B | |
-9.20% | 195B | |
-5.14% | 145B |
- Stock Market
- Equities
- CTLT Stock
- News Catalent, Inc.
- Baird Cuts Catalent Price Target to $45 From $49, Maintains Neutral Rating